Our findings demonstrate that the ZEB1 transcription factor is a key determinant of melanoma phenotypic plasticity, tumorigenicity, and resistance to MAPKi, by fostering the adaptation to the therapeutic drugs. The gene discussed is ZEB1; the disease is melanoma.